Reaction

Osteitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,510 reports · 50 co-occurring drugs

As of the last recalculation, Osteitis appears in 2,510 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is CHLORHEXIDINE GLUCONATE (PRR 22.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Chlorhexidine Gluconate	25	22.9	23.0
Alendronate Sodium	231	20.8	20.9
Exemestane	52	20.5	20.6
Bicalutamide	25	13.7	13.8
Goserelin	21	13.1	13.1
Risedronate Sodium	47	12.8	12.8
Zoledronic Acid	60	12.7	12.7
Antacid	67	12.0	12.0
Cetiirizine	59	11.8	11.8
Alendronate Sodium Tablet	26	11.7	11.8
Cefuroxime	16	11.7	11.7
Clindamycin Phosphate	40	10.1	10.1
Clindamycin	34	10.1	10.1
Thalidomide	43	9.9	9.9
Anastrozole	40	9.2	9.2
Denosumab	201	8.9	8.9
Melphalan	24	8.8	8.8
Melphalan Hydrochloride	26	8.7	8.7
Calcium Carbonate	68	8.6	8.6
Epoetin Alfa	12	8.4	8.4
Meperidine Hydrochloride	9	8.1	8.1
Cephalexin	21	8.1	8.1
Amoxicillin And Clavulanate Potassium	25	7.7	7.7
Fulvestrant	30	7.6	7.6
Letrozole	54	7.4	7.4
Cetirizine	65	7.1	7.1
Bisacodyl Suppositories	11	7.1	7.1
Biscodyl	11	7.0	7.0
Mirtazapine	75	7.0	7.0
Ketoconazole Foam	12	6.8	6.8
Ketoconazole Cream, 2%	12	6.7	6.7
Anastrozole Tablets	17	6.6	6.6
Citalopram Hydrobromide	83	6.6	6.6
Enalapril	41	6.2	6.2
Clopidogrel Bisulfate	74	6.2	6.2
Erythropoietin	15	6.1	6.1
Human Insulin	9	6.0	6.0
Dexamethasone Sodium Phosphate	7	5.7	5.7
Raloxifene Hydrochloride	9	5.1	5.1
Rifampicin	6	4.9	4.9
Baricitinib	5	4.3	4.3
Eszopiclone	13	4.3	4.3
Bortezomib	45	4.2	4.2
Darbepoetin Alfa	27	4.2	4.2
Gefitinib	4	3.7	3.7
Abiraterone Acetate	15	3.0	3.0
Cortisone Acetate	4	2.7	2.7
Teriparatide	35	2.6	2.6
Bimatoprost	9	2.6	2.6
Bimekizumab	5	1.9	1.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.